Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 17, 2020

SELL
$0.33 - $1.62 $54 - $267
-165 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$1.23 - $2.67 $202 - $440
165 New
165 $0
Q3 2019

Oct 18, 2019

SELL
$1.25 - $5.0 $111 - $445
-89 Closed
0 $0
Q2 2019

Jul 16, 2019

BUY
$1.65 - $6.72 $146 - $598
89 New
89 $0

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $427M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.